SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-054358
Filing Date
2023-05-01
Accepted
2023-05-01 16:11:04
Documents
14
Period of Report
2023-05-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2314115d1_8k.htm   iXBRL 8-K 24904
2 EXHIBIT 99.1 tm2314115d1_ex99-1.htm EX-99.1 3229
6 GRAPHIC tm2314115d1_ex99-1img01.jpg GRAPHIC 7322
  Complete submission text file 0001104659-23-054358.txt   212921

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pahc-20230501.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20230501_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20230501_pre.xml EX-101.PRE 22587
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2314115d1_8k_htm.xml XML 3670
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 23873724
SIC: 2834 Pharmaceutical Preparations